Antioxidant therapy to prevent preeclampsia: a randomized controlled trial

Area of Science:

• Obstetrics and Gynecology
• Nutritional Science
• Clinical Trials

Background:

• Preeclampsia is a serious pregnancy complication.
• Women with chronic hypertension or a history of preeclampsia are at increased risk.
• Antioxidant supplementation is explored as a potential preventative measure.

Purpose of the Study:

• To evaluate the efficacy of combined vitamin C and vitamin E supplementation in reducing preeclampsia incidence.
• To assess the impact of antioxidants on pregnancy outcomes in high-risk women.

Main Methods:

• A randomized, placebo-controlled, double-blind trial involving 739 pregnant women at high risk.
• Participants received daily vitamin C (1,000 mg) and vitamin E (400 IU) or placebo from 12-20 weeks gestation.
• Statistical analyses adjusted for clinical site and risk factors.

Main Results:

• No significant reduction in preeclampsia rates was observed (13.8% vs. 15.6%).
• No differences in gestational age at delivery, perinatal mortality, or other adverse outcomes were found.
• A trend towards higher severe preeclampsia rates was noted in the supplemented group among women without chronic hypertension.

Conclusions:

• Antioxidant supplementation with vitamins C and E did not demonstrate a benefit in preventing preeclampsia in this high-risk population.
• Further research may be needed to explore specific subgroups or alternative interventions.